App tracks brain tumor patients' daily struggles in real time
NCT ID NCT07439302
First seen Mar 02, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This study will test whether a smartphone app called Resilience PRO can help doctors keep track of symptoms and quality of life in 80 people with IDH-mutated glioma (a type of brain tumor) who are starting a new treatment. Participants will answer weekly questionnaires about how they feel, and the app will alert their care team if symptoms get worse. The goal is to see if this approach helps maintain quality of life during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Neuro-oncologie, Hôpital de la Pitié-Salpêtrière
Paris, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.